# ACS Dobfar SPA (Plant #2) – FDA Inspection, May 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa-plant-2/6cf6baac-6fd6-48fe-bc02-6a2b008aa04f
Source feed: FDA_Inspections

> FDA inspection 1205340 of ACS Dobfar SPA (Plant #2), May 16, 2023. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1205340
- Company Name: ACS Dobfar SPA (Plant #2)
- Inspection Date: 2023-05-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Documents

- FDA Inspection 1194303 - 2021-12-03
- FDA Inspection 1099286 - 2019-03-01
- FDA Inspection 1027894 - 2017-07-18
- FDA Inspection 952659 - 2015-11-20
- FDA Inspection 842418 - 2013-07-04

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/brandy-n-lepage/41e679e3-cc2a-4361-bf89-26acbd7deaf8)
- [FDA Associated Person](https://www.keypedia.com/people/mindy-m-chou/3d0e74bf-ad6b-48b5-8b72-cbb29e9c9ce5)

Company: https://www.keypedia.com/companies/acs-dobfar-spa-plant-2/334c9ae3-385e-4162-a53a-d53e34111e29

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
